v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Stock Option Activity and Weighted Average Exercise Prices
The following table summarizes the Company’s stock option activity and weighted-average exercise prices:
Number of
Options
Outstanding
Weighted-
Average
Exercise Price		Weighted-
Average
Remaining
Contractual
Life (in Years)		Aggregate
Intrinsic Value
(in thousands)
Balance—December 31, 20253,474,619 $7.26 3.0$447,294 
Options granted— — 
Options exercised(1,864,259)6.76 
Options forfeited or expired— — 
Balance—June 30, 20261,610,360 $7.83 2.6$406,663 
Exercisable—June 30, 2026
1,610,360 $7.83 2.6$406,663 
Schedule of Activity for Unvested RSUs
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-
Average Grant Date
Fair Value
Unvested and outstanding balance as of December 31, 202516,700,043 $124.10 
Awarded4,803,875 139.15
Vested(3,560,961)109.59
Forfeited/canceled(843,601)129.31
Unvested and outstanding balance as of June 30, 202617,099,356 130.40
Schedule of Activity for Unvested PSUs
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-
Average Grant Date
Fair Value
Unvested and outstanding balance as of December 31, 202516,700,043 $124.10 
Awarded4,803,875 139.15
Vested(3,560,961)109.59
Forfeited/canceled(843,601)129.31
Unvested and outstanding balance as of June 30, 202617,099,356 130.40
Schedule of Stock-based Compensation Expense
Stock-based compensation expense was included in the condensed consolidated statement of operations as follows (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Cost of revenue$9,256 $6,783 $17,815 $13,434 
Research and development131,682 112,445 255,353 218,180 
Sales and marketing47,098 37,442 89,396 71,567 
General and administrative32,215 23,792 54,529 41,546 
Stock-based compensation, net of amounts capitalized220,251 180,462 417,093 344,727 
Capitalized stock-based compensation expense6,882 5,957 16,071 11,619 
Total stock-based compensation expense$227,133 $186,419 $433,164 $356,346